These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9238054

  • 1. Demonstration of a novel circulating anti-prostacyclin receptor antibody.
    Kahn NN, Bauman WA, Sinha AK.
    Proc Natl Acad Sci U S A; 1997 Aug 05; 94(16):8779-82. PubMed ID: 9238054
    [Abstract] [Full Text] [Related]

  • 2. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury.
    Kahn N, Sinha A, Bauman W.
    Clin Physiol; 2001 Jan 05; 21(1):60-6. PubMed ID: 11168298
    [Abstract] [Full Text] [Related]

  • 3. Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury.
    Kahn NN, Bauman WA, Sinha AK.
    Proc Natl Acad Sci U S A; 1996 Jan 09; 93(1):245-9. PubMed ID: 8552614
    [Abstract] [Full Text] [Related]

  • 4. Platelet-stimulated thrombin and PDGF are normalized by insulin and Ca2+ channel blockers.
    Kahn NN.
    Am J Physiol; 1999 May 09; 276(5):E856-62. PubMed ID: 10329979
    [Abstract] [Full Text] [Related]

  • 5. Appearance of a novel prostacyclin receptor antibody and duration of spinal cord injury.
    Kahn NN, Bauman WA, Sinha AK.
    J Spinal Cord Med; 2005 May 09; 28(2):97-102. PubMed ID: 15889696
    [Abstract] [Full Text] [Related]

  • 6. Circulating heavy chain IgG, a pathological mediator for coronary artery disease, recognizes platelet surface receptors of both prostacyclin and insulin.
    Kahn NN, Bauman WA, Sinha AK.
    Platelets; 2003 Jun 09; 14(4):203-10. PubMed ID: 12850828
    [Abstract] [Full Text] [Related]

  • 7. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul 09; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 8. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
    Eggerman TL, Andersen NH, Robertson RP.
    J Pharmacol Exp Ther; 1986 Mar 09; 236(3):568-73. PubMed ID: 2869139
    [Abstract] [Full Text] [Related]

  • 9. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M, Nicosia S, Paoletti R, Whittle BJ, Moncada S, Vane JR.
    Prostaglandins; 1984 Feb 09; 27(2):321-33. PubMed ID: 6326201
    [Abstract] [Full Text] [Related]

  • 10. Human prostacyclin platelet receptors in diabetes mellitus.
    Modesti PA, Fortini A, Gensini GF, Vanni D, Prisco D, Abbate R.
    Thromb Res; 1991 Sep 01; 63(5):541-8. PubMed ID: 1755006
    [Abstract] [Full Text] [Related]

  • 11. Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease.
    Kahn NN, Mueller HS, Sinha AK.
    Circ Res; 1990 Apr 01; 66(4):932-40. PubMed ID: 2156636
    [Abstract] [Full Text] [Related]

  • 12. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
    Virgolini I, Li S, Sillaber C, Majdic O, Sinzinger H, Lechner K, Bettelheim P, Valent P.
    J Biol Chem; 1992 Jun 25; 267(18):12700-8. PubMed ID: 1377673
    [Abstract] [Full Text] [Related]

  • 13. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition.
    Siess W, Lapetina EG.
    Biochem J; 1990 Nov 01; 271(3):815-9. PubMed ID: 1700902
    [Abstract] [Full Text] [Related]

  • 14. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
    Fortini A, Modesti PA, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Res; 1985 Nov 01; 40(3):319-28. PubMed ID: 3001968
    [Abstract] [Full Text] [Related]

  • 15. The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics.
    Eggerman TL, Hartzell CJ, Selfe S, Andersen NH.
    Thromb Res; 1987 Mar 01; 45(5):645-59. PubMed ID: 3296302
    [Abstract] [Full Text] [Related]

  • 16. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V, Stemerman M, Schafer A, Adelman B, Smith M, Fuhro R, Salzman E.
    J Lab Clin Med; 1985 Nov 01; 106(5):551-61. PubMed ID: 2997353
    [Abstract] [Full Text] [Related]

  • 17. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B.
    Mol Pharmacol; 1990 Jul 01; 38(1):46-53. PubMed ID: 1695318
    [Abstract] [Full Text] [Related]

  • 18. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
    Kajikawa N, Nogimori K, Murata T, Nishio S, Uchiyama S.
    Arzneimittelforschung; 1989 Apr 01; 39(4):495-9. PubMed ID: 2665758
    [Abstract] [Full Text] [Related]

  • 19. Platelet prostacyclin binding in coronary artery disease.
    Jaschonek K, Karsch KR, Weisenberger H, Tidow S, Faul C, Renn W.
    J Am Coll Cardiol; 1986 Aug 01; 8(2):259-66. PubMed ID: 3016061
    [Abstract] [Full Text] [Related]

  • 20. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
    Li SR, Yang Q, Koller E, Kurtaran A, Bischof C, Leimer M, Rauscha F, Pidlich J, Virgolini I.
    Arterioscler Thromb Vasc Biol; 1997 Oct 01; 17(10):2066-73. PubMed ID: 9351373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.